Recon: AbbVie, Voyager Partner on Gene Therapy for Alzheimer’s; Aimmune’s Peanut Allergy Drug Meets Goals in … – Regulatory Focus
Regulatory Focus |
Recon: AbbVie, Voyager Partner on Gene Therapy for Alzheimer's; Aimmune's Peanut Allergy Drug Meets Goals in …
Regulatory Focus Recon: AbbVie, Voyager Partner on Gene Therapy for Alzheimer's; Aimmune's Peanut Allergy Drug Meets Goals in Phase III. Posted 20 February 2018 | By Michael Mezher. Recon: AbbVie, Voyager Partner on Gene Therapy for Alzheimer's; Aimmune's Peanut … |
